Solara Active Pharma Sciences Ltd.

₹653.8

17.1 (2.7%)

SOLARA Share Price

Pharmaceuticals & Biotechnology

As on October 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 3,153.23 Cr

P/E Ratio-392.72

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	631.13	Bullish
10-DMA	643.57	Bullish
20-DMA	664.38	Bearish
50-DMA	666.58	Bearish
100-DMA	608.49	Bullish
200-DMA	554.03	Bullish

Historical Performance

1 Year

11.2%

3 Years

129.6%

5 Years

-43.3%

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	13,690	12,838	12,889	14,438	12,683
Total Expenditure	11,822	10,775	13,841	13,099	11,884
Other Income	62	83	54	225	200
Operating Profit	1,929	2,146	-898	1,564	1,000
Interest	948	1,148	1,051	901	753
Depreciation	997	992	1,033	1,112	1,123
Profit Before Tax	-74	5	-4,884	-448	-911
Consolidated Net Profit	-74	5	-5,674	-222	-582
Adjusted EPS	-2	---	-145	-6	-15

Compounded Sales Growth

10 Years:21.3

5 Years:-3.3

3 Years:-1.1

TTM:1.3

Compounded Profit Growth

10 Years:46.8

5 Years:-59

3 Years:-19.7

TTM:36.6

Stock Price CAGR

10 Years:N/A

5 Years:-10.6

3 Years:31.9

TTM:9.8

Return on Equity

10 Years:N/A

5 Years:-14.9

3 Years:-145.3

last year:-1.7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	445	402	360	360	360
Total Reserves	12,030	10,507	8,963	14,632	14,879
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,831	1,908	1,715	2,171	2,992
Other Current Liabilities	1,053	1,214	1,675	1,444	1,738
Short Term Borrowings	5,008	5,729	7,603	6,488	6,099
Total Liabilities	23,326	22,318	23,510	28,207	28,898
Capital Work in Progress	2,048	2,800	2,564	2,385	2,386
Long Term Loans & Advances	303	275	238	285	546
Currents Investments	30	---	---	---	---
Short Term Loans and Advances	285	516	524	603	1,089
Total Current Assets	8,581	7,287	7,881	11,875	12,393
Total Assets	23,326	22,318	23,510	28,207	28,898
Adjusted Book Value	280	271	239	384	390

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -392.72, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 31.8%, indicating sustained price appreciation.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹1929 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹13690 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1097716.6

No. of Shares: 1679 (Approx)

Performance:9.8%

97716.6

NIFTY Performance: -12.9%

1 day Top Gainers